We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
The FDA regulatory landscape has significantly changed in 2026, marked by the removal of the two-trial requirement and the introduction
The pharmaceutical industry in India is experiencing unprecedented growth, with tablet and capsule manufacturers expanding their presence across domestic and
Why GCP Audits Matter Clinical research moves quickly. Protocols evolve, sites expand, timelines tighten, and sponsors face constant pressure to
The FDA continues issuing warning letters and inspection observations tied to Good Clinical Practice (GCP) failures, particularly involving inadequate informed
China’s pharmaceutical manufacturing environment is entering a new phase of regulatory oversight in 2026. The National Medical Products Administration (NMPA)
Clinical trial oversight in Europe is changing rapidly with the implementation of ICH E6(R3) and increasing emphasis on risk-based quality
Recent clinical development trends show that sponsors are increasingly using PK/PD analysis, model-informed drug development (MIDD), AI-supported pharmacokinetic workflows, and
At Zenovel, our team is responsible for transforming integrated biologics support by offering a comprehensive framework that facilitates the transition
The global pharmaceutical industry is evolving faster than ever. Drug developers are under pressure to accelerate innovation, reduce research timelines,
Clinical trials today move at a completely different pace than they did even five years ago. Sponsors are under pressure
The pharmaceutical and biotechnology industry is entering one of the most inspection-intensive periods in recent years. Regulatory agencies including the
The clinical research industry is entering a new phase in 2026. Across global markets, sponsors, CROs, and research organizations are
In the highly regulated life sciences industry, organizations must maintain strict compliance with FDA regulations and Good Clinical Practice (GCP)
In the highly regulated pharmaceutical industry, ensuring compliance with GAMP 5 (Good Automated Manufacturing Practice) guidelines is critical for maintaining
Ensuring regulatory compliance is a critical step in the pharmaceutical, biotech, and medical device industries. End-to-End Computer System Validation (CSV)
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Write to us : bd@zenovel.com
Copyright © 2026 Zenovel. All rights reserved.
